UniProt ID | PROS_HUMAN | |
---|---|---|
UniProt AC | P07225 | |
Protein Name | Vitamin K-dependent protein S | |
Gene Name | PROS1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 676 | |
Subcellular Localization | Secreted. | |
Protein Description | Anticoagulant plasma protein; it is a cofactor to activated protein C in the degradation of coagulation factors Va and VIIIa. It helps to prevent coagulation and stimulating fibrinolysis.. | |
Protein Sequence | MRVLGGRCGALLACLLLVLPVSEANFLSKQQASQVLVRKRRANSLLEETKQGNLERECIEELCNKEEAREVFENDPETDYFYPKYLVCLRSFQTGLFTAARQSTNAYPDLRSCVNAIPDQCSPLPCNEDGYMSCKDGKASFTCTCKPGWQGEKCEFDINECKDPSNINGGCSQICDNTPGSYHCSCKNGFVMLSNKKDCKDVDECSLKPSICGTAVCKNIPGDFECECPEGYRYNLKSKSCEDIDECSENMCAQLCVNYPGGYTCYCDGKKGFKLAQDQKSCEVVSVCLPLNLDTKYELLYLAEQFAGVVLYLKFRLPEISRFSAEFDFRTYDSEGVILYAESIDHSAWLLIALRGGKIEVQLKNEHTSKITTGGDVINNGLWNMVSVEELEHSISIKIAKEAVMDINKPGPLFKPENGLLETKVYFAGFPRKVESELIKPINPRLDGCIRSWNLMKQGASGIKEIIQEKQNKHCLVTVEKGSYYPGSGIAQFHIDYNNVSSAEGWHVNVTLNIRPSTGTGVMLALVSGNNTVPFAVSLVDSTSEKSQDILLSVENTVIYRIQALSLCSDQQSHLEFRVNRNNLELSTPLKIETISHEDLQRQLAVLDKAMKAKVATYLGGLPDVPFSATPVNAFYNGCMEVNINGVQLDLDEAISKHNDIRAHSCPSVWKKTKNS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
47 | Gamma-carboxyglutamic_acid | RRANSLLEETKQGNL HHHHHHHHHHHCCCH | 69.76 | 2820795 | |
47 | 4-carboxyglutamate | RRANSLLEETKQGNL HHHHHHHHHHHCCCH | 69.76 | - | |
47 | Gamma-carboxyglutamic_acid | RRANSLLEETKQGNL HHHHHHHHHHHCCCH | 69.76 | 2820795 | |
48 | 4-carboxyglutamate | RANSLLEETKQGNLE HHHHHHHHHHCCCHH | 62.36 | - | |
48 | Gamma-carboxyglutamic_acid | RANSLLEETKQGNLE HHHHHHHHHHCCCHH | 62.36 | 2820795 | |
48 | Gamma-carboxyglutamic_acid | RANSLLEETKQGNLE HHHHHHHHHHCCCHH | 62.36 | 2820795 | |
55 | Gamma-carboxyglutamic_acid | ETKQGNLERECIEEL HHHCCCHHHHHHHHH | 50.89 | 2820795 | |
55 | Gamma-carboxyglutamic_acid | ETKQGNLERECIEEL HHHCCCHHHHHHHHH | 50.89 | 2820795 | |
55 | 4-carboxyglutamate | ETKQGNLERECIEEL HHHCCCHHHHHHHHH | 50.89 | - | |
57 | Gamma-carboxyglutamic_acid | KQGNLERECIEELCN HCCCHHHHHHHHHCC | 30.39 | 2820795 | |
57 | 4-carboxyglutamate | KQGNLERECIEELCN HCCCHHHHHHHHHCC | 30.39 | - | |
57 | Gamma-carboxyglutamic_acid | KQGNLERECIEELCN HCCCHHHHHHHHHCC | 30.39 | 2820795 | |
60 | 4-carboxyglutamate | NLERECIEELCNKEE CHHHHHHHHHCCHHH | 57.48 | - | |
60 | Gamma-carboxyglutamic_acid | NLERECIEELCNKEE CHHHHHHHHHCCHHH | 57.48 | 2820795 | |
60 | Gamma-carboxyglutamic_acid | NLERECIEELCNKEE CHHHHHHHHHCCHHH | 57.48 | 2820795 | |
61 | 4-carboxyglutamate | LERECIEELCNKEEA HHHHHHHHHCCHHHH | 38.42 | - | |
61 | Gamma-carboxyglutamic_acid | LERECIEELCNKEEA HHHHHHHHHCCHHHH | 38.42 | 2820795 | |
61 | Gamma-carboxyglutamic_acid | LERECIEELCNKEEA HHHHHHHHHCCHHHH | 38.42 | 2820795 | |
66 | 4-carboxyglutamate | IEELCNKEEAREVFE HHHHCCHHHHHHHHC | 42.78 | - | |
66 | Gamma-carboxyglutamic_acid | IEELCNKEEAREVFE HHHHCCHHHHHHHHC | 42.78 | 2820795 | |
66 | Gamma-carboxyglutamic_acid | IEELCNKEEAREVFE HHHHCCHHHHHHHHC | 42.78 | 2820795 | |
67 | Gamma-carboxyglutamic_acid | EELCNKEEAREVFEN HHHCCHHHHHHHHCC | 55.42 | 2820795 | |
67 | Gamma-carboxyglutamic_acid | EELCNKEEAREVFEN HHHCCHHHHHHHHCC | 55.42 | 2820795 | |
67 | 4-carboxyglutamate | EELCNKEEAREVFEN HHHCCHHHHHHHHCC | 55.42 | - | |
70 | Gamma-carboxyglutamic_acid | CNKEEAREVFENDPE CCHHHHHHHHCCCCC | 59.62 | 2820795 | |
70 | 4-carboxyglutamate | CNKEEAREVFENDPE CCHHHHHHHHCCCCC | 59.62 | - | |
70 | Gamma-carboxyglutamic_acid | CNKEEAREVFENDPE CCHHHHHHHHCCCCC | 59.62 | 2820795 | |
73 | Gamma-carboxyglutamic_acid | EEAREVFENDPETDY HHHHHHHCCCCCCCC | 66.94 | 2820795 | |
73 | Gamma-carboxyglutamic_acid | EEAREVFENDPETDY HHHHHHHCCCCCCCC | 66.94 | 2820795 | |
73 | 4-carboxyglutamate | EEAREVFENDPETDY HHHHHHHCCCCCCCC | 66.94 | - | |
77 | Gamma-carboxyglutamic_acid | EVFENDPETDYFYPK HHHCCCCCCCCCCHH | 58.12 | 2820795 | |
77 | 4-carboxyglutamate | EVFENDPETDYFYPK HHHCCCCCCCCCCHH | 58.12 | - | |
77 | Gamma-carboxyglutamic_acid | EVFENDPETDYFYPK HHHCCCCCCCCCCHH | 58.12 | 2820795 | |
78 | Phosphorylation | VFENDPETDYFYPKY HHCCCCCCCCCCHHH | 41.19 | - | |
91 | Phosphorylation | KYLVCLRSFQTGLFT HHHHHHHHHHCCHHH | 14.57 | 22210691 | |
98 | O-linked_Glycosylation | SFQTGLFTAARQSTN HHHCCHHHHHHHCCC | 25.17 | OGP | |
104 | Phosphorylation | FTAARQSTNAYPDLR HHHHHHCCCCCCCHH | 18.61 | - | |
104 | O-linked_Glycosylation | FTAARQSTNAYPDLR HHHHHHCCCCCCCHH | 18.61 | OGP | |
110 | Phosphorylation | STNAYPDLRSCVNAI CCCCCCCHHHHHHCC | 3.62 | - | |
122 | Phosphorylation | NAIPDQCSPLPCNED HCCCCCCCCCCCCCC | 24.68 | - | |
122 | O-linked_Glycosylation | NAIPDQCSPLPCNED HCCCCCCCCCCCCCC | 24.68 | OGP | |
136 | Hydroxylation | DGYMSCKDGKASFTC CCCEECCCCCEEEEE | 69.06 | - | |
259 | Phosphorylation | CAQLCVNYPGGYTCY HHHHHHCCCCCEEEE | 5.26 | - | |
266 | Phosphorylation | YPGGYTCYCDGKKGF CCCCEEEEECCCCCE | 5.93 | - | |
297 | Phosphorylation | PLNLDTKYELLYLAE ECCCCCHHHHHHHHH | 17.57 | 27461979 | |
301 | Phosphorylation | DTKYELLYLAEQFAG CCHHHHHHHHHHHHH | 19.25 | 27461979 | |
312 | Phosphorylation | QFAGVVLYLKFRLPE HHHHHHHEEEECCCC | 9.02 | 27461979 | |
331 | Phosphorylation | SAEFDFRTYDSEGVI EEEEECCEECCCCEE | 31.51 | 25072903 | |
332 | Phosphorylation | AEFDFRTYDSEGVIL EEEECCEECCCCEEE | 17.14 | 25072903 | |
334 | Phosphorylation | FDFRTYDSEGVILYA EECCEECCCCEEEEE | 26.32 | 25072903 | |
340 | Phosphorylation | DSEGVILYAESIDHS CCCCEEEEEEECCCH | 9.37 | 25072903 | |
343 | Phosphorylation | GVILYAESIDHSAWL CEEEEEEECCCHHHH | 25.74 | 25072903 | |
347 | Phosphorylation | YAESIDHSAWLLIAL EEEECCCHHHHHHHH | 19.86 | 25072903 | |
394 | Phosphorylation | SVEELEHSISIKIAK CHHHHCCCEEEEEHH | 14.51 | 24719451 | |
396 | Phosphorylation | EELEHSISIKIAKEA HHHCCCEEEEEHHHH | 22.35 | 24719451 | |
423 | Phosphorylation | PENGLLETKVYFAGF CCCCCEEEEEEECCC | 26.27 | 29083192 | |
499 | N-linked_Glycosylation | QFHIDYNNVSSAEGW EEEEECCCCCCCCCE | 28.90 | UniProtKB CARBOHYD | |
509 | N-linked_Glycosylation | SAEGWHVNVTLNIRP CCCCEEEEEEEEEEC | 14.25 | UniProtKB CARBOHYD | |
530 | N-linked_Glycosylation | MLALVSGNNTVPFAV EEEEEECCCCCCEEE | 33.23 | 16335952 | |
531 | N-linked_Glycosylation | LALVSGNNTVPFAVS EEEEECCCCCCEEEE | 46.08 | 2940598 | |
562 | N-linked_Glycosylation | ENTVIYRIQALSLCS ECCCHHHHHHHHHCC | 1.25 | 16335952 | |
594 | Phosphorylation | STPLKIETISHEDLQ CCCEEEEECCHHHHH | 31.11 | 28270605 | |
596 | Phosphorylation | PLKIETISHEDLQRQ CEEEEECCHHHHHHH | 28.39 | 28270605 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PROS_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PROS_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PROS_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FA5_HUMAN | F5 | physical | 10593904 | |
RSSA_HUMAN | RPSA | physical | 21988832 | |
TBK1_HUMAN | TBK1 | physical | 21988832 | |
C4BPB_HUMAN | C4BPB | physical | 9628846 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
612336 | Thrombophilia due to protein S deficiency, autosomal dominant (THPH5) | |||||
614514 | Thrombophilia due to protein S deficiency, autosomal recessive (THPH6) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-530, AND MASSSPECTROMETRY. |